Jennifer Mitchell

8PUBLICATIONS
17CO-AUTHORS
Child and adolescent developmentMedical infection agents (incl. prions)Toxicology (incl. clinical toxicology)Biologically active moleculesPsychopharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 10, 2025
Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.

Nicky J Mehtani, Maha N Mian, Gabrielle Agin-Liebes

|Oct 07, 2024
Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Jennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk

|Sep 14, 2023
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Jennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk

|Jul 21, 2023
Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism.

Jennifer M Mitchell, Brian T Anderson

|Oct 12, 2021
Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy.

Jennifer Mitchell, Allison Coker, Berra Yazar-Klosinski

|May 11, 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein

Pageof 2